Decision Record
Vanity or Vice
Skincare Intelligence

Skin-lightening and 'whitening' products: what to check

Some lightening and whitening creams contain mercury, hidden steroids or unapproved hydroquinone. How to read a label, and what to do if you're worried.

Education, not a diagnosis. Only a clinician who examines your skin can say what you have. Every point below shows how strong the evidence is and links to its source.

Who it affects

  • Anyone buying skin creams can come across these products. FDA reports mercury-containing lighteners are often sold online and in some shops serving Latino, Asian, African and Middle Eastern communities.[1,2]Established
  • They stay available online, including in countries where they are banned.[3,4]Established
  • Mercury is a particular danger for pregnant and nursing people and for young children.[1]Established
  • Ochronosis from long-term hydroquinone use has been reported mainly in people with skin of color. In one case series, people had used lightening creams for many years on average.[5,6]Thin

What helps

Two different goals

Your natural skin tone is not a problem to fix.

  • Evening out a dark mark or a melasma patch and lightening your overall skin tone are different goals. Dermatology guidance on marks focuses on calming the cause, sun protection and gentle care.[7,8]Mechanistic only
  • Products sold as whitening, lightening or bleaching are meant to reduce overall skin pigment. That label does not show they treat a medical pigment condition.[2,9]Mechanistic only

Check the label for mercury

  • Mercury is illegally added to some skin lighteners and anti-aging creams.[1]Established
  • Label words that mean mercury: mercurous chloride, calomel, mercuric, mercurio, or mercury.[1]Established
  • FDA testing has found some creams with very high mercury levels. They were marketed as whitening, bleaching or brightening, came from several countries, and were sold on large online marketplaces.[2]Established
  • Mercury can harm the kidneys, the nervous system and the skin.[1,2]Established

If a product might contain mercury

These are the FDA's steps.

  • Stop using the product, and wash your hands and any skin that touched it.[1]Established
  • Contact poison control or a health professional.[1]Established
  • Seal the product in a bag.[1]Established

Hidden steroids

  • Some lightening creams contain strong steroids that are not on the label, and bans have not stopped them being widely available.[4,7,10]Supported
  • In one reported case, lab testing found a potent steroid in an unlabeled lightening cream. Long use caused facial redness and darkening, then severe acne after stopping.[10]Thin
  • In another case, a steroid-containing lightening cream bought without a prescription was linked to adrenal insufficiency, a whole-body hormone problem.[11]Thin
  • These are single cases, so they cannot show how common hidden steroids are.[10,11]Thin

Hydroquinone: what it is and where it stands

  • Hydroquinone reduces pigment in the upper skin. It is used for melasma and dark marks with professional oversight.[6,12]Supported
  • In the US, from September 2020, over-the-counter skin lighteners containing hydroquinone needed FDA approval to be sold legally, and none are approved.[2,9,13]Established
  • When FDA issued its 2022 notice, the only FDA-approved hydroquinone product was a prescription cream for melasma. It is also prescription-only in the UK, New Zealand and many other countries.[6,9,14]Supported
  • Reported harms from unapproved products include rash, facial swelling and ochronosis. Irritation is more likely at higher strengths.[6,9]Established
  • Ochronosis is blue-black darkening, seen mostly on the cheeks, forehead and temples after long-term use. It may be permanent and is hard to treat.[5,9]Supported

Warning signs on a product

  • Cues linked to the risky products FDA found: whitening, bleaching or brightening marketing on an imported or unregulated product, hydroquinone on a US over-the-counter product, any mercury term, or no ingredient list at all.[1,2,10]Established
  • These are cues, not proof. Many legitimate products use the word brightening.[2]Mechanistic only
  • If you are unsure about a product, a pharmacist or clinician can help you check it.[1]Mechanistic only

What to avoid

  • Any product listing mercurous chloride, calomel, mercuric, mercurio or mercury.[1]Established
  • Creams with no ingredient list, and imported creams that may contain unlisted steroids or mercury.[7,10]Mechanistic only
  • Putting liquid bleach on skin.[7]Mechanistic only
  • Using hydroquinone for long stretches without a clinician.[5,6]Supported
  • Restarting a lightening cream to calm redness or acne that appeared after stopping it. That pattern can point to a hidden steroid and needs medical review.[10,11]Thin
  • Using lightening products while pregnant or breastfeeding, or around young children, without talking to a clinician.[1]Mechanistic only

When to see a clinician

  • You have used a cream that may contain mercury. Contact poison control or a health professional.[1]Established
  • Blue-grey or blue-black darkening appears where you used a lightening cream.[5,6]Thin
  • Your face became red, burning or broke out badly after stopping a lightening cream.[10]Thin
  • You feel generally unwell while using, or after stopping, a lightening cream.[1,11]Thin
  • You have been using hydroquinone for months without supervision.[6,9]Mechanistic only

Label claims to question

“Whitening, lightening or bleaching”
Signals the product aims to reduce overall skin pigment. It does not show it is free of harm. In the US, over-the-counter skin-lightening drug products are not legally marketed, and such products have been found with mercury, hydroquinone or hidden steroids.[1,2,9,10]
“Brightening”
Usually a cosmetic claim about radiance or evenness, and not a regulated term. Some illegal mercury or hydroquinone products were sold as brightening, so the word is not a safety signal in either direction.[2,15,16]
“Dark spot corrector”
Implies targeting marks, not overall tone. It does not show it works, or that it won't irritate. A US over-the-counter hydroquinone corrector is not legally marketed.[9,17,18]
“Melanin-safe or safe for dark skin”
May mean a brand designed for or tested on deeper skin. No regulatory definition was found, and it does not show low irritation or low risk of marks for you.[19,20]
“Hydroquinone-free”
Tells you hydroquinone is not listed. It does not show the product works, irritates less, or is free of other hidden ingredients.[2,21,22]

Where the evidence is thin

  • How common hidden steroids are in lightening creams is unknown. The sources are case reports and one older review.
  • How often people are exposed to mercury through these products is not known from the sources reviewed.
  • No source identified a length of use or strength of hydroquinone that avoids ochronosis.
  • A review says hydroquinone is banned in the EU, Japan and Australia, but whether that covers only cosmetics or prescription medicines too was not confirmed from regulators.
  • The FDA notices describe the US. Rules elsewhere differ and were checked only for the UK and New Zealand.

Keep going

Sources

Retrieved and read for this guide; reviewed 2026-09-13. A source listed here says what it establishes and what it does not — a citation is not an endorsement.

  1. [1]Mercury Poisoning Linked to Skin Products · US Food and Drug Administration, Consumer Updates, 2022Establishes: Mercury is illegally added to some skin lighteners and anti-ageing creams. Label terms to watch: mercurous chloride, calomel, mercuric, mercurio, mercury. These products are often sold in shops serving Latino, Asian, African and Middle Eastern communities, and online. Health effects are listed, and if exposed FDA's steps are to stop use, wash, contact poison control, and seal the product.Does not establish: That every unlabelled product contains mercury, or how common exposure is.
  2. [2]FDA Warns Consumers of Skin Products Containing Mercury and/or Hydroquinone · US Food and Drug Administration (Health Fraud), 2026Establishes: FDA testing since 2019 found some lighteners with mercury at 47 to 27,762 ppm and/or hydroquinone. The products were marketed as whitening, bleaching or brightening, came from several countries, and were sold on large online marketplaces. Kidney, nerve and skin harms are listed. Repeats that there are no legal OTC lighteners in the US.Does not establish: Steroid adulteration, which it does not cover. It does not show that every product using the word 'brightening' contains these ingredients.
  3. [3]Mercury in skin lightening products · World Health Organization, 2019Establishes: Mercury-containing lighteners are hazardous and banned in many countries but are still sold online. Governments are urged to act under the Minamata Convention.Does not establish: A specific ppm limit, which the fetched page did not state. It did not discuss steroids.
  4. [4]Widespread use of toxic skin lightening compounds: medical and psychosocial aspects · Dermatol Clin, 2011 · read at abstract levelEstablishes: Hydroquinone and topical corticosteroids are used for melasma and for cosmetic lightening, with many skin and systemic complications. Bans have not substantially reduced availability.Does not establish: Which specific steroids are involved, or prevalence figures — those were not read.
  5. [5]Exogenous Ochronosis: Characterizing a Rare Disorder in Skin of Color · J Clin Med 12(13):4341, 2023 · read at abstract levelEstablishes: Retrospective case series with review. In 25 patients with exogenous ochronosis, the average lightening-cream use was 9.2 years. The blue-black pigment appeared mostly on the cheeks, forehead and temples. The condition mainly affects people with skin of colour and is distressing.Does not establish: Risk per user, or any duration or concentration that carries no risk — a case series cannot identify either.
  6. [6]Hydroquinone (bleaching cream) · DermNet (NZ), 2021Establishes: Hydroquinone inhibits tyrosinase and acts on epidermal (not dermal) pigment. The typical course described is twice daily for about 3 months, stopped if there is no improvement, then twice-weekly maintenance. Risks include irritant dermatitis (more likely above 4%) and exogenous ochronosis with prolonged high-concentration use. It is prescription-only in NZ and many countries.Does not establish: A universal maximum duration — it sets none. Legal status outside NZ is not detailed.
  7. [7]How to fade dark spots in darker skin tones · American Academy of Dermatology, 2025Establishes: Advises tinted broad-spectrum SPF30+ sunscreen with iron oxide and treating the underlying cause. Lists azelaic, glycolic and kojic acids, retinoids and vitamin C as ingredients. Says to avoid irritating products, liquid bleach, and imported products with unlisted steroids or mercury. Fading takes 6–12 months for lighter spots and can take years for deeper ones.Does not establish: Any ranking of the ingredients, or trial evidence for them. Not individual advice.
  8. [8]Postinflammatory Hyperpigmentation (StatPearls) · NCBI Bookshelf (Lawrence, Syed, Al Aboud), 2024Establishes: PIH is more common in Fitzpatrick IV–VI; up to 65% in darker-skinned acne patients. Triggers include acne, dermatitis, infections, lasers, peels, cryotherapy and burns. Epidermal PIH resolves in about 6–12 months; dermal PIH is slow and may be permanent. Prevention: sunscreen, gentle care, not picking, treating inflammation early. Combination therapy is described as most effective.Does not establish: Systematic grading — it is not a systematic review. Does not discuss niacinamide or tranexamic acid.
  9. [9]FDA works to protect consumers from potentially harmful OTC skin lightening products · US Food and Drug Administration (Drug Safety Communication), 2022Establishes: Under the CARES Act, over-the-counter skin lighteners containing hydroquinone needed FDA approval to be legally marketed from 23 September 2020, and there are no approved OTC skin lighteners. Reported harms include rash, facial swelling and exogenous ochronosis, which may be permanent. At the date of the notice (April 2022) the only FDA-approved hydroquinone product was a prescription triple-combination cream for melasma.Does not establish: That hydroquinone does not work — the finding is regulatory, not about efficacy. It says nothing about prescription products after April 2022, or about any market outside the US: the EU cosmetics ban this entry used to mention is not on this page.
  10. [10]Unregulated skin-lightening cream use causing topical steroid-induced dermatitis and nodulocystic acne · BMJ Case Rep, 2025 · read at abstract levelEstablishes: An unlabeled lightening cream was found on analysis to contain undisclosed clobetasol propionate 0.05%. After 12 months of use it caused facial redness, progressive darkening, and severe acne after stopping.Does not establish: How common steroid adulteration is — a single case.
  11. [11]Hypoadrenalism secondary to topical corticosteroid-containing skin-lightening cream · Med J Aust, 2015 · read at abstract levelEstablishes: Adrenal insufficiency (a systemic harm) occurred after using a steroid-containing lightening cream bought without prescription.Does not establish: How often this happens — a single case.
  12. [12]Topical Hydroquinone for Hyperpigmentation: A Narrative Review · Cureus 15(11):e48840, 2023 · read at abstract levelEstablishes: Hydroquinone is effective for melasma and PIH, has multiple side effects, and should be used under professional oversight. It is not approved OTC in the US. The abstract says it is banned in Japan, Australia and the EU.Does not establish: The scope of those bans — the abstract does not detail them, and they may cover cosmetics rather than prescription use. Cureus is a low-barrier journal.
  13. [13]Skin Facts! What You Need to Know About Skin Lightening Products · US Food and Drug Administration, 2026Establishes: FDA runs a consumer education initiative warning that OTC lighteners with hydroquinone or mercury are not approved.Does not establish: Much beyond the FDA drug safety communication on OTC skin lighteners (fda_lightening_2022).
  14. [14]Melasma (Patient Hub leaflet) · British Association of Dermatologists, 2024Establishes: Up to 50% of pregnant women may be affected. Melasma is more common in people of colour and people who tan easily. Triggers: hormones, UV, sunbeds, possibly high-energy visible light. SPF50+ with iron oxide is advised. Hydroquinone is prescription-only with limited-duration use. Lists triple cream, azelaic acid, cysteamine, thiamidol and tranexamic acid. Procedures risk worsening, especially in people of colour. There is no cure and relapse is common.Does not establish: The 50% pregnancy figure, which it does not source, or any efficacy comparison between the treatments it lists.
  15. [15]Efficacy of topical vitamin C in melasma and photoaging: A systematic review · J Cosmet Dermatol, 2023 · read at abstract levelEstablishes: Across 7 studies and 139 volunteers, topical vitamin C showed lightening, and long-term use may be needed.Does not establish: An optimal concentration, or PIH-specific results. Very small evidence base.
  16. [16]The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer · Br J Dermatol, 2002 · read at abstract levelEstablishes: Lab work plus small clinical trials. Niacinamide inhibited melanosome transfer (35–68% in coculture) without inhibiting tyrosinase, and reduced hyperpigmentation versus vehicle after 4 weeks in small trials.Does not establish: Results in PIH-specific or skin-of-colour-specific cohorts — the trials were short and small. Company-affiliated research (not assessed further).
  17. [17]Postinflammatory hyperpigmentation · DermNet (NZ), 2015Establishes: PIH is more intense and longer-lasting in darker skin. Inflammation drives melanin production, with an epidermal form and a dermal (macrophage) form. Physical treatments can worsen PIH by injuring the epidermis.Does not establish: Any trial data or comparative efficacy — it gives none. The page was last updated in December 2015.
  18. [18]Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color · J Clin Aesthet Dermatol 3(7):20–31, 2010Establishes: PIH is more frequent and more severe in darker skin. Cites a 2002 acne study reporting PIH in 65.3% of African-American, 52.7% of Hispanic and 47.4% of Asian acne patients. Explains epidermal vs dermal PIH. First-line care is treating the underlying inflammation plus photoprotection and depigmenting agents; treatment irritation can worsen PIH. Agents covered: hydroquinone 2–4% (ochronosis risk with prolonged use), azelaic acid 20%, retinoids (irritation in up to about 50%), niacinamide, kojic acid (contact dermatitis common), vitamin C. Glycolic and salicylic peels need care. Longer laser wavelengths are described as lower-risk.Does not establish: Graded evidence — it is a narrative review, 16 years old. The survey figures are secondary citations; the primary study was not fetched.
  19. [19]Complications of laser and light-based devices therapy in patients with skin of color · Indian J Dermatol Venereol Leprol, 2019Establishes: Higher epidermal melanin in types IV–VI absorbs laser energy non-selectively, raising the chance of PIH, hypopigmentation, burns, scarring and keloids. Prevention described: longer wavelengths (1064 nm Nd:YAG), conservative fluence and longer pulses, cooling, test spots, sun avoidance, counselling. IPL carries a paradoxical hair-growth risk in darker skin.Does not establish: Pooled complication rates — it is an expert symposium review, not a systematic review.
  20. [20]Laser hair removal: FAQs · American Academy of Dermatology, 2026Establishes: Darker skin can be treated but needs particular care and an experienced board-certified dermatologist skilled in lasers. Possible side effects include burns, scarring, and lightening or darkening of the skin, sometimes permanent. Sun protection is needed before and after.Does not establish: Which wavelengths or laser types are used, or how often complications occur.
  21. [21]Efficacy and safety of cysteamine 5% cream for melasma: systematic review and meta-analysis of RCTs · Arch Dermatol Res, 2024 · read at abstract levelEstablishes: 7 randomised trials: cysteamine beat placebo, with no significant difference from hydroquinone 4%. Irritation rates were similar to hydroquinone and higher than placebo.Does not establish: That cysteamine and hydroquinone are equivalent — few, small trials cannot show that.
  22. [22]Treatment of Post-Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review · J Cutan Med Surg 28(5), 2024 · read at abstract levelEstablishes: Across 48 studies and 1,356 people (70% Black), partial improvement was seen in 85% on topical retinoids and 66% on lasers. Laser monotherapy sometimes worsened PIH. Chemical peels and hydroquinone showed lower efficacy in this dataset.Does not establish: A ranking — the studies are heterogeneous and mostly uncontrolled.
Near-black ground, following the device